August 2021 - Page 31 of 42

MondayAug 09, 2021 1:57 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Rolling out Rapid Disease Testing in Canada, Plans to Expand into US and UK Markets

Avricore Health has announced that it is ready to roll out its HealthTab rapid disease testing system in pharmacies across Canada The rapid disease testing system comprises two key components, Avricore’s web-based HealthTab and Abbott’s Affinion 2 multi-assay analyzer The global point-of-care diagnostics market was valued at $34.49 billion in 2020 and is expected to continue growing and reach $81.37 billion by 2028 Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), an innovator in pharmacy services focused on the acquisition and development of early-stage technology aimed to move pharmacies forward, is set to roll out its proprietary HealthTab rapid disease testing system…

MondayAug 09, 2021 1:44 pm

Flora Growth Corp. (NASDAQ: FLGC) Receives Fair Value Estimate, Coverage from Argus Research Company; Developing Growth Opportunities by Columbia’s Cannabis Law, Headquarter Relocation

Flora Growth Corp recently received coverage from Argus Research, which gives the company’s stock a fair value estimate of $7.50 against the $3.24 recorded July 20 Argus also projects that Flora’s revenue would increase to $9 million in 2021 and $31 million in 2022, up from $0.1 million reported in 2020 Flora received a boost in its operations when Colombia’s president accepted and signed reforms to the existing cannabis legislation The updated law allows for the manufacture, sale and export of psychoactive (high-THC) cannabinoid ingestible and medical products and removes marketing limitations on cannabis products in Colombia Flora is also…

MondayAug 09, 2021 1:10 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) and Its Quest to Build an Industry-Leading, Rare Cannabinoid Enterprise

InMed announced a non-binding letter of intent to acquire BayMedica Inc. The move is designed to grow InMed’s market presence and strengthen its operations The two companies have had a reciprocal research collaboration that dates back to November 2020 InMed looks to capitalize on the growing cannabinoid industry that is projected to grow at a CAGR of 21.2% from 2021 to 2028 InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company committed to developing cannabinoid-based pharmaceutical drug candidates. It also manufactures technologies for pharmaceutical-grade rare cannabinoids. It is known for creating a pipeline of cannabinoid-based pharmaceutical drug candidates to treat various…

MondayAug 09, 2021 12:19 pm

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) Investor Presentation Available On Demand

Nextech AR Solutions (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), an emerging leader in augmented reality (“AR”) for eCommerce, AR learning applications, AR-enhanced video conferencing and virtual events, was a presenter for the OTCQB Venture Investor Conference, which was held Aug. 5, 2021. Nextech’s presentation, along with presentations by other companies that participated in the conference, is available for on-demand viewing by interested individuals, institutional investors and advisors. The event was hosted by Virtual Investor Conferences, the leading proprietary investor conference series, which also hosts the archived presentations. According to the announcement, all presentations will be available for 24/7…

MondayAug 09, 2021 12:06 pm

Brain Scientific Inc. (BRSF) Positioned to Disrupt EEG Market with Cost-Effective Brain Imaging Devices

Brain Scientific poised to disrupt neurology market with two new FDA-cleared patented products that provide cost-effective brain imaging in any setting Current global market for EEG devices estimated at $956.1 million with CAGR of 8.7% from 2019 to 2026, expected to reach $1.6 billion by 2026 With a focus on developing innovative and proprietary medical devices and software, Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, is fulfilling its mission of modernizing and increasing accessibility to brain diagnostics with two new FDA-cleared products that provide next-generation solutions to the neurology market. Already patented in the United States, China and…

MondayAug 09, 2021 11:56 am

QualityStocksNewsBreaks – Mobius Interactive Ltd.’s Venture into Brazilian Market Well-Calculated, Perfectly-Timed

Mobius Interactive, an online esports and gaming operator, recently signed a lucrative sponsorship agreement to display its flagship brand, Mobius.bet, on national TV in Brazil for the 2021 FIFA World Cup Qualifiers. This agreement with Brazil’s largest television station, Globo TV, marks the company’s entry into the expanding Brazilian iGaming Industry, projected to grow at a CAGR of 11.4% between 2018 and 2023, ultimately posting total revenues of $6.29 billion. “This venture into the Brazilian market is well-calculated and perfectly-timed,” explains a recent article. “Mobius Interactive is pulling out all the stops in Brazil, getting in early to capitalize on…

MondayAug 09, 2021 11:47 am

QualityStocksNewsBreaks – Emaginos Inc.’s EdManage Analytics Platform Holds Potential to Make Profound Impact on Education

Emaginos, a REG-A public company (please see website if interested in investing) in the business of transforming K-12 public education, recently filed a patent for its EdManage Analytics Platform, titled “Education Analytics Platform.” The EdManage analytics platform aggregates and analyzes all of a district’s data and then provides previously unattainable actionable information for optimizing every aspect of the district’s operations. A recent article reads, “Emaginos believes its EdManage system has potential to make a profound impact on education. The system integrates all of the devices and applications within a school system that traditionally operate independently, creating cohesive information that can…

MondayAug 09, 2021 11:40 am

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Unveils Direct-to-Consumer Hearing Aid on Health-E Commerce Network

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer hearing-health technology space, announced that it is working with Health-E Commerce and its broad network. Through Health-E Commerce’s online stores, FSAstore.com and HSAstore.com, INND will provide its medical-grade, direct-to-consumer hearing aids along with other hearing products. The company noted that more than 70 million consumers are enrolled in tax-advantaged flexible spending accounts (“FSAs”) and health savings accounts (“HSAs”), and those consumers shop in those online stores. InnerScope will also offer its direct-to-consumer hearing aids on Health-E Commerce’s WellDeservedHealth.com online marketplace, dedicated to individuals who participate in workplace wellness and health incentive programs. Health-E Commerce is…

MondayAug 09, 2021 11:39 am

QualityStocksNewsBreaks – StorEn Technologies Inc.’s Proprietary Product Is Game Changer for Residential, Industrial Energy Storage

StorEn Technologies, currently in the process of a RegA offering with four different investment tiers, has developed a revolutionary vanadium flow battery technology that has the potential to transform the energy-storage space. StorEn’s batteries, which deliver superior performances at a lower cost, have a proven ability to discharge fully at 100% without decaying or losing capacity, unlike lithium batteries. Further, because the battery management system alerts the user when service is needed, consumers no longer need to schedule regular maintenance. A recent article reads, “With a proprietary product that answers the call for long-lasting, 100% recyclable, safe, and affordable energy…

MondayAug 09, 2021 11:17 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Conference Call to Discuss Q2 2021 Financial Results

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), has scheduled a conference call and live webcast for Aug. 12, 2021, to begin at 5 p.m. ET. The purpose of the call is to discuss the company’s second-quarter financial results, which Vivos plans to release after market close on the same day. The call will also include an overview of the company’s recent milestones and growth strategy. Those interested may access the call by dialing (888) 204-4368; international callers…

Site Search

Company Search

Month: August 2021